Page last updated: 2024-10-27

gabexate and Bacterial Disease

gabexate has been researched along with Bacterial Disease in 4 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Research Excerpts

ExcerptRelevanceReference
"Ciprofloxacin is considered to be a safe and effective treatment for acute infectious colitis."7.80Acute pancreatitis secondary to ciprofloxacin therapy in patients with infectious colitis. ( Cheung, DY; Cho, HJ; Cho, SH; Kim, JI; Kim, JK; Kim, SS; Lee, HJ; Sung, HY, 2014)
"We investigated FOY therapy for the treatment of disseminated intravascular coagulation (DIC) associated with sepsis in 15 patients (group F), and compared it with heparin therapy in 8 patients (group H)."5.27Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis. ( Hirata, T; Kambayashi, J; Nishijima, MK; Shimada, Y; Taenaka, N; Takezawa, J; Yoshiya, I, 1983)
"Ciprofloxacin is considered to be a safe and effective treatment for acute infectious colitis."3.80Acute pancreatitis secondary to ciprofloxacin therapy in patients with infectious colitis. ( Cheung, DY; Cho, HJ; Cho, SH; Kim, JI; Kim, JK; Kim, SS; Lee, HJ; Sung, HY, 2014)
"We investigated FOY therapy for the treatment of disseminated intravascular coagulation (DIC) associated with sepsis in 15 patients (group F), and compared it with heparin therapy in 8 patients (group H)."1.27Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis. ( Hirata, T; Kambayashi, J; Nishijima, MK; Shimada, Y; Taenaka, N; Takezawa, J; Yoshiya, I, 1983)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sung, HY1
Kim, JI1
Lee, HJ1
Cho, HJ1
Cheung, DY1
Kim, SS1
Cho, SH1
Kim, JK1
Taenaka, N1
Shimada, Y1
Hirata, T1
Nishijima, MK1
Takezawa, J1
Yoshiya, I1
Kambayashi, J1
Tamakuma, S1
Yamada, K1

Reviews

1 review available for gabexate and Bacterial Disease

ArticleYear
[Newborn infants and disseminated intravascular coagulation].
    Rinsho byori. The Japanese journal of clinical pathology, 1985, Volume: Spec No 63

    Topics: Bacterial Infections; Blood Coagulation Tests; Diagnosis, Differential; Disseminated Intravascular C

1985

Other Studies

3 other studies available for gabexate and Bacterial Disease

ArticleYear
Acute pancreatitis secondary to ciprofloxacin therapy in patients with infectious colitis.
    Gut and liver, 2014, Volume: 8, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infectio

2014
Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis.
    Critical care medicine, 1983, Volume: 11, Issue:9

    Topics: Adult; Aged; Anticoagulants; Bacterial Infections; Disseminated Intravascular Coagulation; Female; G

1983
[Severe surgical infection and DIC].
    Nihon Geka Gakkai zasshi, 1983, Volume: 84, Issue:9

    Topics: Adult; Aged; Animals; Bacterial Infections; Blood Coagulation Factors; Disseminated Intravascular Co

1983